The National Institutes of Health (NIH) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies.
Sponsoring Agency: National Institutes of Health (NIH)
Type of Fund: Grant
Deadline Available: Available
Deadline Date (mm/dd/yyyy): 04/05/2024
Size of the Fund: More than $1 Million
The National Institutes of Health (NIH) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies.
NeuroNEXT provides a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations. While the network is not specific to one disease, it has the capacity to coordinate a cadre of specialist investigators to implement studies efficiently in response to disease-specific opportunities.
Funding Information
Applicants should rarely exceed $1,000,000 in total cost per year for a Phase I and $1,500,000 in total cost per year for a Phase II/Phase IIB.
Eligibility Criteria
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. A small business concern is one that, at the time of award of Phase I and Phase II, meets all of the following criteria:
• Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor;
• Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture;
• Has, including its affiliates, not more than 500 employees.
More information at: https://www.grants.gov/web/grants/view-opportunity.html?oppId=333352
Eligible Countries:
United States
